EA199800829A1 - Индуцирующий апоптоз продукт и способ его получения, индуктор апоптоза и способ индуцирования апоптоза, индуктор для дифференциации канцерогенных клеток, пищевой продукт, фармацевтические композиции и гигиеническое средство - Google Patents

Индуцирующий апоптоз продукт и способ его получения, индуктор апоптоза и способ индуцирования апоптоза, индуктор для дифференциации канцерогенных клеток, пищевой продукт, фармацевтические композиции и гигиеническое средство

Info

Publication number
EA199800829A1
EA199800829A1 EA199800829A EA199800829A EA199800829A1 EA 199800829 A1 EA199800829 A1 EA 199800829A1 EA 199800829 A EA199800829 A EA 199800829A EA 199800829 A EA199800829 A EA 199800829A EA 199800829 A1 EA199800829 A1 EA 199800829A1
Authority
EA
Eurasian Patent Office
Prior art keywords
apoptosis
product
differentiation
preparation
pharmaceutical compositions
Prior art date
Application number
EA199800829A
Other languages
English (en)
Other versions
EA001535B1 (ru
Inventor
Нобуто Кояма
Хироаки Сагава
Ейдзи Кобаяси
Тацудзи Еноки
Хуа-Канг Ву
Ейдзи Нисияма
Сузу Дегути
Кацусиге Икаи
Хирому Охноги
Мотоко Уеда
Акихиро Кондо
Икуносин Като
Original Assignee
Такара Сузо Ко., Лтд
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27525188&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA199800829(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Такара Сузо Ко., Лтд filed Critical Такара Сузо Ко., Лтд
Publication of EA199800829A1 publication Critical patent/EA199800829A1/ru
Publication of EA001535B1 publication Critical patent/EA001535B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals
    • C07H7/033—Uronic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927—Diagnostic contrast agent
    • Y10S977/928—X-ray agent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927—Diagnostic contrast agent
    • Y10S977/929—Ultrasound contrast agent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927—Diagnostic contrast agent
    • Y10S977/93—MRI contrast agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Продукт, полученный тепловой обработкой, по крайней мере, одного вещества, выбранного из нижеследующих (а), (b) и (с):(a) уроновая кислота или производное уроновой кислоты;(b) сахаридное соединение, содержащее уроновую кислоту, или сахаридное соединение, содержащее производное уроновой кислоты; и(c) вещество, содержащее сахаридное соединение, содержащее уроновую кислоту, или вещество, содержащее сахаридное соединение, содержащее производное уроновой кислоты;и продукт питания, напиток или фармацевтическое средство, отличающееся тем, что оно содержит вышеупомянутый теплообработанный продукт.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199800829A 1996-03-15 1997-02-25 Индуцирующий апоптоз продукт и способ его получения, индуктор апоптоза и способ индуцирования апоптоза, индуктор для дифференциации канцерогенных клеток, пищевой продукт, фармацевтические композиции и гигиеническое средство EA001535B1 (ru)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP8597296 1996-03-15
JP17441196 1996-06-14
JP23371996 1996-08-16
JP27523196 1996-09-27
JP32590096 1996-11-22
PCT/JP1997/000527 WO1997033593A1 (fr) 1996-03-15 1997-02-25 Produit obtenu par traitement thermique d'acide uronique, et aliments, boissons ou medicaments contenant ce produit

Publications (2)

Publication Number Publication Date
EA199800829A1 true EA199800829A1 (ru) 1999-02-25
EA001535B1 EA001535B1 (ru) 2001-04-23

Family

ID=27525188

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800829A EA001535B1 (ru) 1996-03-15 1997-02-25 Индуцирующий апоптоз продукт и способ его получения, индуктор апоптоза и способ индуцирования апоптоза, индуктор для дифференциации канцерогенных клеток, пищевой продукт, фармацевтические композиции и гигиеническое средство

Country Status (10)

Country Link
US (3) US6482806B1 (ru)
EP (1) EP0888776A4 (ru)
JP (1) JP4302186B2 (ru)
KR (1) KR19990087665A (ru)
CN (1) CN1114410C (ru)
AU (1) AU1735097A (ru)
CA (1) CA2248648A1 (ru)
EA (1) EA001535B1 (ru)
TW (1) TW510798B (ru)
WO (1) WO1997033593A1 (ru)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69926994T2 (de) * 1998-01-19 2006-06-22 Takara Bio Inc., Otsu Substanzen, welche apoptose einleiten können
JP3982916B2 (ja) * 1998-07-31 2007-09-26 タカラバイオ株式会社 抗ヘリコバクター・ピロリ剤
JP4532612B2 (ja) * 1998-10-29 2010-08-25 生化学工業株式会社 Ｆａｓ抗原発現増強剤
JP2001012967A (ja) * 1999-04-28 2001-01-19 Asahi Optical Co Ltd エンコーダおよび磁気式エンコーダを搭載した測量機
US6167625B1 (en) 1999-05-18 2001-01-02 Warner-Lambert Company Shaving implement
JP2003508468A (ja) * 1999-09-06 2003-03-04 バイゼル ギュンター 長時間持続性の満腹効果を得るための架橋された薬剤及びその製法
DE10006989A1 (de) * 2000-02-16 2001-08-23 Nutricia Nv Antiadhäsive Kohlenhydratmischung
DE60114122T2 (de) * 2000-06-23 2006-07-13 Sakai, Takuo, Sakai Verfahren zur herstellung einer aus pflanzen stammenden, antibakteriellen substanz
US6677318B1 (en) 2000-09-05 2004-01-13 Beisel Guenther Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said
DE10061574A1 (de) * 2000-12-11 2002-06-13 Josef Peter Guggenbichler Blockierung der Anlagerung von Keimen bei Vögeln
DE10111165A1 (de) * 2001-03-02 2002-10-10 Knoell Hans Forschung Ev Verwendung von Hyaluronsäure-Uroniden zur Behandlung von entzündlichen Vorgängen
US6680306B2 (en) * 2001-06-21 2004-01-20 Glycogenesys, Inc. Method for enhancing the effectiveness of cancer therapies
WO2003041723A1 (de) * 2001-11-12 2003-05-22 Reinmueller Johannes Pharmazeutische anwendungen von hyaluronsäure-präparaten
EP1980257A1 (en) * 2003-04-07 2008-10-15 Prospect Therapeutics, Inc. Compositions and uses of galectin antagonists
US20050053664A1 (en) 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
WO2006078699A2 (en) 2005-01-18 2006-07-27 A.M. Todd Company Oral care compositions derived from the labiatae family
EP1714562A1 (en) * 2005-04-22 2006-10-25 N.V. Nutricia Process for drying uronic acid oligosaccharides
JP5057972B2 (ja) * 2005-06-07 2012-10-24 三栄源エフ・エフ・アイ株式会社 ペクチンの改質方法及びその応用
WO2006131963A1 (ja) * 2005-06-07 2006-12-14 San-Ei Gen F.F.I., Inc. ペクチンの改質方法及びその応用
US20090087537A1 (en) * 2005-09-28 2009-04-02 San-Ei Gen F.F.I., Inc. Emulsion Composition and Method of Preparing the Same
JP4976031B2 (ja) * 2006-03-24 2012-07-18 国立大学法人鳥取大学 ガラクツロン酸を有効成分とする軟骨生成促進剤
JP2007269641A (ja) * 2006-03-30 2007-10-18 Mie Univ 修治技術を取り入れたきのこ類の機能性食品およびその生産方法
JP2007314462A (ja) * 2006-05-25 2007-12-06 Nippon Tablet Kk 外用剤
JP5714329B2 (ja) * 2008-06-24 2015-05-07 株式会社ゲノム創薬研究所 植物体由来の自然免疫活性化作用が増強された自然免疫活性化組成物
JP5491082B2 (ja) * 2008-07-02 2014-05-14 株式会社ゲノム創薬研究所 自然免疫機能活性化組成物の製造方法及び自然免疫機能活性化組成物
US8283463B2 (en) 2010-02-09 2012-10-09 Bausch & Lomb Incorporated Sterile hyaluronic acid solutions
JP6053149B2 (ja) * 2012-03-26 2016-12-27 ＡｄａＢｉｏ株式会社 Ｉｄ遺伝子の発現抑制剤
KR101450098B1 (ko) * 2012-05-04 2014-10-14 동의대학교 산학협력단 푸코이단을 유효성분으로 포함하는 구강 세정용 조성물
KR20170038214A (ko) * 2015-09-30 2017-04-07 (주)아모레퍼시픽 당산 및 플라보노이드를 포함하는 항균용 조성물
JP2019103495A (ja) * 2017-12-14 2019-06-27 康二 岡井 多糖類加熱焙煎飲食品及びその製法
CN110713550B (zh) * 2018-07-12 2022-03-15 浙江省亚热带作物研究所 一种利用虫草培养物制备具有抑菌活性精多糖的方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1082682A (en) * 1913-05-19 1913-12-30 Robert Douglas Food product.
JPS609042B2 (ja) * 1976-03-01 1985-03-07 生化学工業株式会社 酸性多糖体の分取法
KR830002802B1 (ko) * 1978-12-04 1983-12-16 제임스 에프 · 너우톤 박테리아 발효에 의한 다당류 s-60의 제조방법
JPS57163478A (en) * 1981-03-31 1982-10-07 Asama Kasei Kk Preservative for food and drink and preserving method thereof (2)
JPS6023319A (ja) * 1983-07-18 1985-02-05 Nakano Vinegar Co Ltd 抗腫瘍剤
JPS6229947A (ja) 1985-07-31 1987-02-07 Ajinomoto Co Inc 難消化性多糖含有ゲルの製造法
US5252351A (en) * 1986-06-19 1993-10-12 Cox James P Cohesive vegetable products and process for manufacture
WO1991013624A1 (en) * 1990-03-05 1991-09-19 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Endogenous, suramin-induced, sulfated glycosaminoglycans as anti-cancer agents in humans
JPH0418401A (ja) * 1990-05-11 1992-01-22 Tsumura & Co 多糖体および多糖体を有効成分とする抗潰瘍剤
JPH0436228A (ja) * 1990-05-30 1992-02-06 Lion Corp 口腔用組成物
IT1243300B (it) * 1990-12-20 1994-05-26 Fidia Spa Derivati dell'eparina
US5250519A (en) * 1991-03-29 1993-10-05 Glycomed Incorporated Non-anticoagulant heparin derivatives
JP2663408B2 (ja) * 1991-05-09 1997-10-15 明治製菓株式会社 植物の形態形成又は分化の促進方法
US5476842A (en) * 1991-11-04 1995-12-19 Co Enzyme Technology Ltd. Method and compositions for treating tumors having high tyrosinase activity
GB9209997D0 (en) * 1992-05-08 1992-06-24 Unilever Plc Food process
JPH0623319A (ja) * 1992-07-10 1994-02-01 Dainippon Toryo Co Ltd 塗装金属板加工品の製造方法
DE4242539C2 (de) * 1992-12-16 2002-06-06 Thueringisches Inst Textil Verfahren zum Verfestigen von textilen Produkten, hergestellt aus Naturfasern
FR2699370B1 (fr) * 1992-12-17 1995-01-13 Cedilac Sa Procédé pour la fabrication d'un lait infantile liquide prêt à l'emploi longue conservation et anti-régurgitation, et lait ainsi obtenu.
JPH06229947A (ja) * 1993-01-29 1994-08-19 Riken Corp フローティングシートの自動検査装置
DE4313549C1 (de) * 1993-04-26 1994-10-13 Herbstreith & Fox Kg Pektin Fa Verfahren zur Gewinnung von Pektin-Extrakt aus Zuckerrüben und dessen Verwendung
JP3277073B2 (ja) * 1993-12-24 2002-04-22 三菱レイヨン株式会社 水溶性多糖類粉体の製造方法
JP3714426B2 (ja) * 1994-02-01 2005-11-09 株式会社糖鎖工学研究所 フコイダンオリゴ糖組成物含有癌転移抑制剤
US6207652B1 (en) * 1996-01-26 2001-03-27 Takara Shuzo Co., Ltd. Apoptosis inducers

Also Published As

Publication number Publication date
TW510798B (en) 2002-11-21
JP4302186B2 (ja) 2009-07-22
CN1213310A (zh) 1999-04-07
US6482806B1 (en) 2002-11-19
EP0888776A4 (en) 2005-01-26
US20050202064A1 (en) 2005-09-15
WO1997033593A1 (fr) 1997-09-18
AU1735097A (en) 1997-10-01
KR19990087665A (ko) 1999-12-27
CN1114410C (zh) 2003-07-16
EP0888776A1 (en) 1999-01-07
EA001535B1 (ru) 2001-04-23
CA2248648A1 (en) 1997-09-18
US20030176393A1 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
EA199800829A1 (ru) Индуцирующий апоптоз продукт и способ его получения, индуктор апоптоза и способ индуцирования апоптоза, индуктор для дифференциации канцерогенных клеток, пищевой продукт, фармацевтические композиции и гигиеническое средство
EA200100524A1 (ru) Амиды антраниловой кислоты и их применение в качестве лекарственных средств
FI965251A (fi) Verenkolesterolia alentavia mausteiden, ruoka-ainesten ja ruoka-ainekoostumusten valmistusmenetelmä ja tällaisten mausteiden, ruoka-ainesten ja ruoka-aineiden käyttö
ATE218341T1 (de) Zwischenverbindungen von fortgeschrittenen glykosylierung-endprodukten und post-amadorische inhibitor
EA200100002A1 (ru) Бензотиепины, обладающие активностью ингибиторов перемещения желчных кислот в подвздошной кишке и поглощения таурхолата
NL980012I2 (nl) Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen.
IT8020078A0 (it) Procedimento per la polverizzazione di prodotti alimentari ad elevato contenuto di grasso.
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
ES2021607B3 (es) Dispositivo de pasteurizacion de productos alimenticios contenidos enrecipientes.
EA200000240A1 (ru) Соединения, препятствующие эффекту раннего превращения лекарственных средств
ES517519A0 (es) Procedimiento para el tratamiento de frutas, vegetales o productos carnicos.
MA22880A1 (fr) Procede de preparation de produits pharmaceutiques .
IT8620561A0 (it) Procedimento e dispositivo per il trattamento di prodotti di uovo, o relativi composti, per prolungare la durata dei prodotti medesimi.
RU95105167A (ru) Новое применение бензимидазола
IT8421566A0 (it) Sale di due-piperazinopirimidina, procedimento per la sua preparazione e composizioni farmaceutiche che ne contengono.
FR2643303B3 (fr) Procede de decoupage en secteurs de produits circulaires, notamment alimentaires
FR2742975B1 (fr) Vitrine transportable pour la presentation de produits, notamment alimentaires
EA199800546A1 (ru) Производные тиола, обладающие (ace/nep) ингибирующим действием на металлопептидазу
FR2720011B1 (fr) Composition pour le traitement des fruits et légumes par thermonébulisation, et procédé de traitement.
IT1238672B (it) Procedimento e camera di fermentazione per il trattamento di pezzi di pasta alimentare.
FR2654582B1 (fr) Appareil pour fumer, par fumees froides, des denrees alimentaires.
FR2581507B1 (fr) Procede et produits pour la lutte contre le pyrale de la vigne, sparganothis pilleriana
IT8026351A0 (it) Derivato della ammino-penicillina, processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo.
IT8601216A0 (it) Procedimento per la conservazione di prodotti vegetali
IT7946902A0 (it) Impianto sterilizzatore pastorizzatore particolarmente per prodotti ad elevata temperatura di pastorizzazione

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

PC4A Registration of transfer of a eurasian patent by assignment
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU